Publications by Dr Steven Young-Min - ePrints

Browsing publications by Dr Steven Young-Min.

Newcastle Authors	Title	Year
Dr Jessica Tarn Dr Nadia Howard-Tripp Dr Dennis Lendrem Andrew Skelton Dr Katherine James et al.	Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials	2019
Professor Fai Ng Dr Katherine James Dr Bridget Griffiths Dr David Coady Dr Steven Young-Min et al.	Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: Examination of data from the UK Primary Sjögren's Syndrome Registry	2018
Dr Peter Gallagher Sheryl Mitchell Dr Bridget Griffiths Vicki Hindmarsh Ben Hargreaves et al.	Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren’s Syndrome – Capturing the discrepancy	2017
Sheryl Mitchell Dr Katherine James Professor Fai Ng Dr Bridget Griffiths Vicki Hindmarsh et al.	Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry	2016
Dr Jessica Tarn Andini Natasari Colin Gillespie Sheryl Mitchell Dr Katie Hackett et al.	Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines	2016
Dr Katherine James Shereen Al-Ali Dr Jessica Tarn Dr Simon Cockell Dr Colin Gillespie et al.	A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome	2015
Professor Fai Ng Dr Katherine James Dr Bridget Griffiths Dr James Andrews Dr Vadivelu Saravanan et al.	Eligibility for Clinical Trials in Primary Sjogren's Syndrome: Lessons from the UK Primary Sjogren's Registry	2015
Mark Houseman Dr Kate Potter Nicola Marshall Dr Rachel Lakey Emeritus Professor Tim Cawston et al.	Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up	2012
Dr Steven Young-Min Emeritus Professor Tim Cawston Dr David Coady	Biomarkers in the prediction of radiographic progression in early rheumatoid arthritis: Comment on the article by Young-Min et al	2008
Dr Steven Young-Min Emeritus Professor Tim Cawston Dr David Coady	Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers	2007
Dr Steven Young-Min Dr Susan Hudson Dr Clive Kelly	Gross synovial fluid analysis in the differential diagnosis of joint effusion	2007
Dr Steven Young-Min	Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis	2005
Dr Steven Young-Min Dr David Coady Emeritus Professor Tim Cawston	Are biochemical markers predictive of radiographic progression in early rheumatoid arthritis and do they perform better than traditional markers?	2005
Dr Steven Young-Min Dr David Coady Sarah Charlton Emeritus Professor Drew Rowan Emeritus Professor Tim Cawston et al.	Early rheumatoid arthritis patients with DR4 shared epitope alleles progress radiologically and have elevated levels of serum MMP-3, serum comp, urinary GLC-GAL-PYD and urinary collagen crosslinks	2005
Dr Steven Young-Min Dr David Coady Emeritus Professor Tim Cawston	Longitudinal measurement of traditional observer and laboratory based markers enhances prediction of radiographic progression in early rheumatoid arthritis. patient based responses were of limited use	2005
Dr David Coady Dr Steven Young-Min Dr Lesley Kay Dr David Walker	Objective structured clinical examinations (OSCEs) of the musculoskeletal system who should be scoring them?	2005
Dr Steven Young-Min Emeritus Professor Tim Cawston	Serum MMP-3 levels fall following the initiation of methotrexate in patients with early rheumatoid arthritis	2005
Dr Steven Young-Min Emeritus Professor Drew Rowan Sarah Charlton Dr David Coady Emeritus Professor Tim Cawston et al.	The biallelic 1G/2G single nucleotide polymorphism at position-1607BP of the MMP-1 promoter is not associated with rheumatoid arthritis, does not significantly affect measured levels of serum MMP-1 and is not associated with increased radiographic destruction	2005
Dr Steven Young-Min Emeritus Professor Tim Cawston	The dominant role of serum MMP-3 compared to serum MMP-1 and MMP-13 in the generation of breakdown products from joint tissues in patients with early rheumatoid arthritis	2005
Dr Steven Young-Min Dr John Fordham	Weekly alendronate-induced acute pseudogout [3]	2005
Dr Steven Young-Min	What's new in Rheumatology	2005
Dr Steven Young-Min	Copying clinic letters to patients will place additional demands on both secondary and primary care: A hospital outpatient questionnaire	2004
Dr Steven Young-Min Dr Bijayeswar Vaidya	CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy	2004
Dr Steven Young-Min Dr Vadivelu Saravanan	A survey of fibromyalgia in medical students	2003
Dr Steven Young-Min Emeritus Professor Tim Cawston Angela Grainger	Modified Larsen scoring of digitized radiographs in rheumatoid arthritis	2003
Dr Bijayeswar Vaidya Professor Simon Pearce Stephen Charlton Emeritus Professor Drew Rowan Professor Pat Kendall-Taylor et al.	An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies	2002
Dr Steven Young-Min Professor Simon Pearce Dr Bijayeswar Vaidya	Re: An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies, by Vaidya et al. - Reply	2002
Dr Steven Young-Min Professor Simon Pearce Dr Bijayeswar Vaidya	Reply Re: An association between the CTLA-4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies	2002
Dr Steven Young-Min Emeritus Professor Tim Cawston	Leader: markers of joint destruction: principles, problems and potential	2001
Dr Steven Young-Min Emeritus Professor Tim Cawston	Markers of joint destruction: principles, problems, and potential	2001
Dr Steven Young-Min Emeritus Professor Tim Cawston	Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls	2001